Hillsdale Investment Management’s Prothena Corp PRTA Stock Holding History

Hillsdale Investment Management’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-31,300	Closed	-$1.51M	–	633
2023 Q3	$1.51M	Sell	31,300 -6,100	-16%	-$362K	0.14%	185
2023 Q2	$2.55M	Sell	37,400 -27,600	-42%	-$1.78M	0.23%	154
2023 Q1	$3.15M	Sell	65,000 -12,500	-16%	-$660K	0.27%	132
2022 Q4	$4.67M	Buy	+77,500	New	+$4.54M	0.39%	87
2022 Q1	–	Sell	-93,500	Closed	-$4.62M	–	599
2021 Q4	$4.62M	Hold	93,500	–	–	0.31%	115
2021 Q3	$6.66M	Buy	93,500 +41,700	+81%	+$2.59M	0.51%	41
2021 Q2	$2.66M	Buy	+51,800	New	+$1.62M	0.21%	143

Other funds holding PRTA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hillsdale Investment Management's PRTA Position: Q4 2023 in Review

Hillsdale Investment Management sold out of Prothena Corp (PRTA) in Q4 2023, closing a stake of 31,300 shares — an estimated $1.51M sold.

Hillsdale Investment Management first reported a position in PRTA in Q2 2021 and held it in 7 quarters. The position peaked at $6.66M in Q3 2021. 187 funds tracked by Wall St. Rank hold PRTA as of Q4 2023.

Hillsdale Investment Management reported no remaining Prothena Corp position as of Q4 2023 after selling out during the quarter.
Hillsdale Investment Management sold 31,300 Prothena Corp shares in Q4 2023, an estimated $1.51M.
Hillsdale Investment Management first reported a position in Prothena Corp in Q2 2021 and held it in 7 quarters.
Hillsdale Investment Management's Prothena Corp position peaked at $6.66M in Q3 2021.
187 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2023.

Based on Hillsdale Investment Management's 13F filing for Q4 2023, filed 9 Feb 2024.